AVEO PHARMACEUTICALS INC - COM (AVEO)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
27,577,625
Share change
-5,179,289
Total reported value
$41,247,854
Put/Call ratio
467%
Price per share
$1.50
Number of holders
64
Value change
-$9,221,610
Number of buys
25
Number of sells
40

Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q1 2014

As of 31 Mar 2014, AVEO PHARMACEUTICALS INC - COM (AVEO) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,577,625 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, GREAT POINT PARTNERS LLC, Sarissa Capital Management LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, Palo Alto Investors, LLC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., and State Street Corp. This page lists 64 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.